HOME >> MEDICINE >> NEWS
New data at ASCO show CAMPTOSAR is key to treating 1st line metastatic colorectal cancer

aluated the impact of adding bevacizumab to FOLFIRI and mIFL. A statistically significant improvement in OS for patients treated with FOLFIRI plus bevacizumab was seen when compared with those receiving mIFL plus bevacizumab. A total of 87 percent of patients were still alive after one year compared to 61 percent of patients given mIFL plus bevacizumab. The most frequent grade 3/4 adverse events in both arms were diarrhea, neutropenia and hypertension, with neutropenia and hypertension being higher in the FOLFIRI plus bevacizumab arm.

"This study enhances our understanding of combining FOLFIRI with the targeted agent bevacizumab as a standard treatment in first-line metastatic colorectal cancer patients," said Dr. Fuchs. "FOLFIRI plus bevacizumab significantly improved OS when compared to mIFL plus bevacizumab and both regimens were tolerable."


'"/>

Contact: Rachel Leopold
rachel.leopold@edelman.com
212-704-4433
Edelman Public Relations
5-Jun-2006


Page: 1 2

Related medicine news :

1. Study shows radiofrequency ablation highly effective in treating kidney tumors
2. Tumor cell activity may provide clues for treating breast cancer in young women
3. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
4. Help for pediatricians in treating behavioral health problems only partially successful
5. ECP may be effective in treating Crohns disease
6. New guideline for treating Lyme disease
7. Certain combination therapy found more effective for treating malaria in African children
8. Article outlines current recommendations for treating malaria in the US
9. One pill may be better than two for treating patients with high blood pressure
10. Effectiveness of first renin inhibitor drug for treating hypertension is limited
11. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

Post Your Comments:
(Date:6/30/2015)... ... July 01, 2015 , ... Avid boxing style rock concert poster collector, Andrew ... concert posters. The Who and the Rascals also played at this concert in New ... Doors played with the Who backing them up. The Doors gave a very stirring ...
(Date:6/30/2015)... ... ... Carey Danis & Lowe comments on a new pretrial order ... court. The court document outlined the judge’s plan to consolidate 26 vaginal mesh lawsuits. ... & Lowe is a personal injury law firm with headquarters in St. Louis. The ...
(Date:6/30/2015)... ... , ... America is in a health crisis. Today, 4 out of 5 ... Why? , The answer is simple and is at the core of every disease ... treated over one million patients and, for the first time ever, gives readers and ...
(Date:6/30/2015)... ... ... they have slashed prices across the board for the Phantom of the Opera in ... “The Phantom of the Opera” has been a hit on musical stages around the United ... a musical by Andrew Lloyd Webber won a Tony Award for “Best Musical." The ...
(Date:6/30/2015)... ... , ... The American Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as ... Attorney Award respectively. As of July 1, 2015, the firm and Mr. Brown personally ... New Jersey. The award is a culmination of the hard work, long hours, and ...
Breaking Medicine News(10 mins):Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3Health News:12 Easy-To-Follow Steps to Transform Body, Mind and Spirit 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2
(Date:6/30/2015)... Legal-Bay LLC, the Lawsuit Settlement Funding Company, ... multidistrict litigation (MDL) over the Zimmer NexGen Knee implant ... , 2015. There are currently more than a thousand ... a federal judge in Illinois . ... begin in October of this year. Zimmer Inc. previously ...
(Date:6/29/2015)... -- , Gerresheimer will sell its borosilicate glass ... into a 10-year-supply agreement for pharmaceutical glass tubing ... Corning and Gerresheimer will form a joint ... Gerresheimer,s outlook for the financial years 2016 to ... tubing business , In line with its strategy ...
(Date:6/29/2015)... 29, 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ... credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby ... of secured debt financing. CareView is an information technology ... monitoring. Under the credit agreement, PDL will ... financing in two tranches of $20 million, based upon ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4
Cached News: